Find therapies in clinical trials near you – page 66

Study Comparing Nivolumab with Ipilimumab or Nivolumab with Chemotherapy to Chemotherapy Alone in Patients with Early Stage Non-Small Cell Lung Cancer

Study Comparing Nivolumab with Ipilimumab or Nivolumab with Chemotherapy to Chemotherapy Alone in Patients with Early Stage Non-Small Cell Lung Cancer

Study on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma

Study on Nivolumab for Preventing Melanoma Recurrence in Patients with Completely Removed Stage IIB/C Melanoma

Study on the Effects of GLPG3667 for Adults with Dermatomyositis

Study on the Effects of GLPG3667 for Adults with Dermatomyositis

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette's Disorder

Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette's Disorder

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Study of Relatlimab and Nivolumab for Patients with Advanced Liver Cancer Who Have Not Received Immunotherapy After Tyrosine Kinase Inhibitor Treatment

Study of Relatlimab and Nivolumab for Patients with Advanced Liver Cancer Who Have Not Received Immunotherapy After Tyrosine Kinase Inhibitor Treatment

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack